US7027121000 - Common Stock
PASSAGE BIO INC
NASDAQ:PASG (4/24/2024, 4:27:26 PM)
1.24
+0.01 (+0.81%)
Passage Bio, Inc. operates as a genetic medicines company. The company is headquartered in Philadelphia, Pennsylvania and currently employs 85 full-time employees. The company went IPO on 2020-02-28. The firm is focused on developing transformative therapies for central nervous system (CNS) disorders. Its first product candidate, PBGM01, utilizes a AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal beta-galactosidase (B-gal), for GM1. Its second product candidate, PBFT02, utilizes an AAV1 capsid to deliver to the brain a functional GRN gene encoding progranulin (PGRN), for FTD caused by progranulin deficiency (FTD-GRN). The firm has two programs in the research stage: PBAL05 for amyotrophic lateral sclerosis (ALS), and an unnamed program for Huntington’s disease. PBAL05 is targeting patients with ALS who have a gain-of-function mutation in the C9orf72 gene. The company also has an exploratory research program for larger non-monogenic indications, which is focused on temporal lobe epilepsy (TLE).
PASSAGE BIO INC
One Commerce Square, 2005 Market Street, 39Th Floor
PHILADELPHIA PENNSYLVANIA 19103
P: 12678660312
CEO: Bruce Goldsmith
Employees: 85
Website: https://www.passagebio.com/
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the...
PASG stock results show that Passage Bio beat analyst estimates for earnings per share the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Passage Bio (NASDAQ:PASG) just reported results for the fourth quarter of 2023....
$10,000 scholarship to be awarded to a rising junior with a life science major attending a Pennsylvania-based four-year college or university Scholarship...
Here you can normally see the latest stock twits on PASG, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: